Appendix 3Y Change of Director's Interest Notice

Rule 3.19A.2

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity DigitalX Limited

ABN 59 009 575 035

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director

Peter Irwin Rubinstein

Date of last notice

15 September 2017

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest

Indirect

Nature of indirect interest (including registered holder)

Note: Provide details of the circumstances giving rise to the relevant interest.

RIP Opportunities Pty Ltd ATF PIR Super Fund. Peter Irwin Rubinstein is the sole director and shareholder of RIP Opportunities Pty Ltd and sole member of PIR Super Fund.

Irwin Biotech Nominees Pty Ltd ATF BIOA Trust. Peter Irwin Rubinstein is the sole director and shareholder of Irwin Biotech Nominees Pty Ltd and a beneficiary of BIOA Trust.

ValueAdmin.Com Pty Ltd. Peter Irwin Rubinstein is the sole director and shareholder

Date of change

14 November 2017 - 21 November 2017

No. of securities held prior to change

Direct

617,284 Subscription Options exercisable at $0.0324 each on or before 1 September 2020

Indirect

17 Convertible Notes with a face value of $10,000 each, converting to fully paid ordinary Shares at $0.027 per Share (6,296,296 Shares) and maturing on 14 September 20181

1,700,000 Convertible Note Options exercisable at

$0.0324 each on or before 14 September 20191

8,000,000 Broker Performance Options exercisable at

$0.0324 each on or before 14 September 20191

10 Convertible Notes with a face value of $10,000 each, converting to fully paid ordinary Shares at $0.027 per Share (3,703,704 Shares) and maturing on 14 September 20182

1,000,000 Convertible Note Options exercisable at

$0.0324 each on or before 14 September 20192

7,000,000 Broker Performance Options exercisable at

$0.0324 each on or before 14 September 20193

  1. Held by Irwin Biotech Nominees Pty Ltd ATF BIOA Trust.

  2. Held by RIP Opportunities Pty Ltd ATF PIR Super Fund.

  3. Held by ValueAdmin.Com Pty Ltd.

Class

Fully Paid Ordinary Shares

Incentive Options exercisable at $0.0324 on or before 14 November 2019

Broker Performance Options exercisable at $0.0324 each on or before 14 September 2019

Convertible Notes with a face value of $10,000, converting to Fully Paid Ordinary Shares at $0.027 per Share and maturing 14 September 2018

Number acquired

14,703,704 Fully Paid Ordinary Shares

2,000,000 Incentive Options exercisable at $0.0324 on or before 14 November 2019

Number disposed

4,724,697 Fully Paid Ordinary Shares

10 Convertible Notes with a face value of $10,000, converting to Fully Paid Ordinary Shares at $0.027 per Share and maturing 14 September 2018

11,000,000 Broker Performance Options exercisable at

$0.0324 each on or before 14 September 2019

Value/Consideration

Note: If consideration is non-cash, provide details and estimated valuation

4,724,697 Shares at an average price $0.2021 per Share

11,000,000 Shares at $0.0324 per Share 3,703,704 Shares at $0.027 per Share

2,000,000 Incentive Options issued for nil consideration

No. of securities held after change

Direct

617,284 Subscription Options exercisable at $0.0324 each on or before 1 September 2020

Indirect

5,000,000 Fully Paid Ordinary Shares1 979,007 Fully Paid Ordinary Shares2 4,000,000 Fully Paid Ordinary Shares3

17 Convertible Notes with a face value of $10,000 each, converting to fully paid ordinary Shares at $0.027 per Share (6,296,296 Shares) and maturing on 14 September 20181

1,700,000 Convertible Note Options exercisable at

$0.0324 each on or before 14 September 20191

1,000,000 Broker Performance Options exercisable at

$0.0324 each on or before 14 September 20191

1,000,000 Convertible Note Options exercisable at

$0.0324 each on or before 14 September 20192

3,000,000 Broker Performance Options exercisable at

$0.0324 each on or before 14 September 20193

2,000,000 Incentive Options exercisable at $0.0324 on or before 14 November 2019

  1. Held by Irwin Biotech Nominees Pty Ltd ATF BIOA Trust.

  2. Held by RIP Opportunities Pty Ltd ATF PIR Super Fund.

  3. Held by ValueAdmin.Com Pty Ltd.

Nature of change

Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

11,000,000 Fully Paid Shares issued on Conversion of 11,000,000 Broker Performance Options exercisable at

$0.0324 expiring 14 September 2019

4,724,697 Fully Paid Shares sold via on market trade.

3,703,704 Shares Issued on Conversion of 10 Convertible Notes with a face value of $10,000, converting to Fully Paid Ordinary Shares at $0.027 per Share and maturing 14 September 2018 (with 2,000,000 free attaching Incentive Options)

DigitalX Limited published this content on 21 November 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 21 November 2017 14:18:06 UTC.

Original documenthttps://daks2k3a4ib2z.cloudfront.net/59f0ff036e24550001e3340f/5a1432e4b3280e0001fc26b5_DCC_Change_of_Directors_Interest_Notice 11-21-17.pdf

Public permalinkhttp://www.publicnow.com/view/4CEFBFD553C37C98A4C142949E0B174FE9D405FE